Latest Share Chat

REMOVE ADS

Poolbeg Pharma Share News (POLB)

Poolbeg Pharma Information

Share Price Information for Poolbeg Pharma (POLB)

Share Price is delayed by 15 minutes

Get Live Data

7.60 -0.10 (-1.30%)

Bid:

7.50

Ask:

7.70

Spread: 0.20 (2.667%)

Market Cap: £53.59m

Last checked at -

Intraday Poolbeg Pharma Share Chart

REMOVE ADS

Poolbeg Pharma News

LONDON MARKET OPEN: FTSE 100 flat as UK data keeps pound above USD1.26

(Alliance News) - Stocks in Europe started the day mixed on Friday, with the FTSE 100 set for a weekly decline, in largely lifeless trade to kick off ...

Poolbeg Pharma shares plummet as Hookipa walks away from possible bid

(Alliance News) - Poolbeg Pharma PLC on Friday said it is "surprised and disappointed" by Hookipa Pharma Inc opting against making a bid for the compa...

LONDON BRIEFING: StanChart announces buyback as 2024 profit climbs

(Alliance News) - London's FTSE 100 is set for a tepid open, continuing a rough week for the blue-chip benchmark, and following the lead of US stocks ...

Hookipa Pharma rules out making offer for Poolbeg Pharma

(Alliance News) - Hookipa Pharma Inc on Thursday said it is not going ahead with a bid for Poolbeg Pharma PLC.

IN BRIEF: Poolbeg Pharma notes Gilead interest in Hookipa fundraise

Poolbeg Pharma PLC - London-based clinical stage biopharmaceutical firm - Updates on Gilead Sciences Inc's intentions regarding potential Hookipa Phar...

Poolbeg Pharma says Gilead in favour of its combination with Hookipa

(Sharecast News) - Poolbeg Pharma updated the market on its potential combination with Hookipa Pharma on Friday, clarifying Gilead Sciences' role in t...

IN BRIEF: Poolbeg and Hookipa deal gets support from major stakeholder

Poolbeg Pharma PLC - London-based clinical stage biopharmaceutical firm - Confirms that Gilead Sciences Inc, a significant shareholder in Hookipa Phar...

LONDON MARKET CLOSE: Pound sinks but FTSE 100 starts 2025 with a bang

(Alliance News) - London's FTSE 100 made an impressive start to the new year, shrugging aside drab manufacturing data, lifted by rising oil majors, go...